September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Evaluation of the IOLMaster 700
Author Affiliations & Notes
  • Mark A Bullimore
    University of Houston, Boulder, Colorado, United States
  • Derek Le
    University of Houston, Boulder, Colorado, United States
  • Gabriel Leche
    University of Houston, Boulder, Colorado, United States
  • Paul Stanley
    University of Houston, Boulder, Colorado, United States
  • Paul Yoo
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Todd Otani
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Footnotes
    Commercial Relationships   Mark Bullimore, Alcon Laboratories (C), Carl Zeiss Meditec (C), Genentech (C), Innovega (C); Derek Le, None; Gabriel Leche, None; Paul Stanley, None; Paul Yoo, Carl Zeiss Meditec (E); Todd Otani, Carl Zeiss Meditec (E)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 912. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Mark A Bullimore, Derek Le, Gabriel Leche, Paul Stanley, Paul Yoo, Todd Otani; Evaluation of the IOLMaster 700. Invest. Ophthalmol. Vis. Sci. 2016;57(12):912.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Optical biometry, based on partial coherence interferometry, is the gold standard for for obtaining precise ocular measurements. The Carl Zeiss Meditec IOLMaster 700 utilizes a newer swept-source OCT technology to obtain all axial measurements, including axial length, anterior chamber depth, corneal thickness, and lens thickness. We evaluated the repeatability and reproducibility of the IOLMaster 700 and its agreement with the IOLMaster 500 and Lenstar LS900.

Methods : Complete biometric measurements were taken on one eye chosen at random of 100 subjects, 51 of whom manifested cataracts (47 to 85 years, BCVA 20/16 to 20/80) and 49 of whom had clear lenses (22 to 58 years). Among the full cohort, there were 42 eyes with corneal astigmatism ≥ 0.75 D. Three sets of biometric measurements were taken by three operators with three different IOLMaster 700 units, and one operator took three measurements with the IOLMaster 500 and the Lenstar LS 900. A random effects model of analysis of variance (ANOVA) was used to estimate the repeatability and reproducibility. The 95% limits of agreement (95% LoA) were calculated for all comparisons using the first acceptable measurements from each instrument.

Results : Comparing the IOLMaster 700 and IOLMaster 500 in cataract patients, 95% LoA were –0.01 to +0.06 mm for axial length, –0.44 to +0.27 D for mean corneal power, and –0.18 to +0.17 mm for anterior chamber depth. Likewise, a comparison between the IOLMaster 700 and the Lenstar LS 900 for corneal thickness and lens thickness yielded 95% LoA of –4 to +13 µm and –0.26 to +0.41 mm, respectively. The repeatability and reproducibility limits for the IOLMaster 700 in cataract patients were ±0.014 and ±0.023 mm for axial length; ±0.26 and ±0.27 D for mean corneal power; ±7 and ±11 µm for corneal thickness; ±0.02 and ±0.02 mm for anterior chamber depth; and ±0.02 and ±0.05 mm for lens thickness. For comparison, the repeatability limits in cataract patients were ±0.043 mm for axial length, ±0.24 D for mean corneal power, and ±0.15 mm for anterior chamber depth for the IOLMaster 500, and ±7 µm for corneal thickness and ±0.27 mm for lens thickness for the Lenstar.

Conclusions : There was good agreement between the IOLMaster 700 and the comparative instruments and superior or equivalent precision. While some statistically significant differences were noted for axial length and mean corneal power, these would not be considered clinically meaningful.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×